WO2002030400A1 - Preparations solides - Google Patents
Preparations solides Download PDFInfo
- Publication number
- WO2002030400A1 WO2002030400A1 PCT/JP2001/008785 JP0108785W WO0230400A1 WO 2002030400 A1 WO2002030400 A1 WO 2002030400A1 JP 0108785 W JP0108785 W JP 0108785W WO 0230400 A1 WO0230400 A1 WO 0230400A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation according
- preparation
- solid preparation
- weight
- parts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/398,434 US7510728B2 (en) | 2000-10-06 | 2001-10-05 | Solid preparations |
EP01974700A EP1329217A4 (en) | 2000-10-06 | 2001-10-05 | SOLID PREPARATIONS |
AU2001294192A AU2001294192A1 (en) | 2000-10-06 | 2001-10-05 | Solid preparations |
CA002424770A CA2424770A1 (en) | 2000-10-06 | 2001-10-05 | Solid pharmaceutical preparation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000313105 | 2000-10-06 | ||
JP2000-313106 | 2000-10-06 | ||
JP2000313106 | 2000-10-06 | ||
JP2000-313105 | 2000-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002030400A1 true WO2002030400A1 (fr) | 2002-04-18 |
Family
ID=26602026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/008785 WO2002030400A1 (fr) | 2000-10-06 | 2001-10-05 | Preparations solides |
Country Status (5)
Country | Link |
---|---|
US (1) | US7510728B2 (ja) |
EP (1) | EP1329217A4 (ja) |
AU (1) | AU2001294192A1 (ja) |
CA (1) | CA2424770A1 (ja) |
WO (1) | WO2002030400A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004030700A1 (ja) * | 2002-10-07 | 2004-04-15 | Takeda Pharmaceutical Company Limited | 固形製剤 |
WO2005037254A1 (ja) * | 2003-10-15 | 2005-04-28 | Fuji Chemical Industry Co., Ltd. | 口腔内速崩壊性錠剤 |
WO2007136129A1 (en) * | 2006-05-23 | 2007-11-29 | Takeda Pharmaceutical Company Limited | Oral preparation comprising pioglitazone |
WO2013129436A1 (ja) * | 2012-02-29 | 2013-09-06 | 武田薬品工業株式会社 | 経口剤 |
US8632808B2 (en) | 2006-04-27 | 2014-01-21 | Takeda Pharmaceutical Company Limited | Taste-masking solid preparation of pioglitazone |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US7985420B2 (en) * | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US8012504B2 (en) * | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US7838032B2 (en) * | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
CN1537005A (zh) * | 2001-04-26 | 2004-10-13 | �����Ƹ���ʽ���� | 无定形头孢托仑匹伏克西路组合物及其制备方法 |
US7071210B2 (en) * | 2002-07-02 | 2006-07-04 | Pfizer Inc. | CETP inhibitors in combination with antihypertensive agents and uses thereof |
US20040253305A1 (en) * | 2003-06-12 | 2004-12-16 | Luner Paul E. | Pharmaceutical compositions of atorvastatin |
RU2361582C2 (ru) * | 2003-06-25 | 2009-07-20 | Новартис Аг | Таблетка, содержащая флувастатин и кармеллозу кальция |
US7838029B1 (en) * | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
ITRM20030485A1 (it) * | 2003-10-22 | 2005-04-23 | Tubilux Pharma S P A | Composizione a base di citicolina in associazione con vitamine per la prevenzione ed il trattamento di patolgie oculari. |
PT1715893E (pt) * | 2004-01-20 | 2009-10-20 | Novartis Pharma Ag | Formulação para compressão directa e processos |
CA2578224A1 (en) * | 2004-08-25 | 2006-03-09 | Essentialis, Inc. | Pharmaceutical formulations of potassium atp channel openers and uses thereof |
ATE518526T1 (de) * | 2005-01-26 | 2011-08-15 | Lek Pharmaceuticals | Neue pharmazeutische zusammensetzung mit candesartan-cilexetil als lipophile kristalline substanz |
GT200600218A (es) * | 2005-06-10 | 2007-03-28 | Formulación y proceso de compresión directa | |
AU2016202290B2 (en) * | 2005-06-17 | 2017-10-05 | Wisconsin Alumni Research Foundation | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
CN103948927B (zh) | 2005-06-17 | 2017-11-07 | 威斯康星校友研究基金会 | 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法 |
TWI347942B (en) * | 2005-06-22 | 2011-09-01 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
US20080274178A1 (en) | 2005-08-10 | 2008-11-06 | Shionogi & Co., Ltd. | Orally Disintegrating Tablet |
JOP20180109A1 (ar) * | 2005-09-29 | 2019-01-30 | Novartis Ag | تركيبة جديدة |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
WO2007072992A2 (en) * | 2005-12-22 | 2007-06-28 | Takeda Pharmaceutical Company Limited | Solid preparation containing an insulin sensitizer |
WO2008018371A1 (fr) * | 2006-08-08 | 2008-02-14 | Kissei Pharmaceutical Co., Ltd. | Comprimé à désagrégation orale ayant un goût amer masqué et son procédé de production |
KR20090049089A (ko) * | 2006-09-05 | 2009-05-15 | 아스트라제네카 아베 | 칸데사르탄 실렉세틸을 포함하는 약학 조성물 |
EP1908469A1 (en) * | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
JP5537927B2 (ja) * | 2007-03-13 | 2014-07-02 | 大日本住友製薬株式会社 | 口腔内崩壊錠 |
ES2586433T3 (es) * | 2007-04-11 | 2016-10-14 | Omeros Corporation | Composiciones y métodos para la profilaxis y el tratamiento de adicciones |
US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
TW200914006A (en) * | 2007-07-12 | 2009-04-01 | Takeda Pharmaceutical | Coated preparation |
EP3093010A1 (en) * | 2007-10-19 | 2016-11-16 | Reckitt Benckiser Healthcare (UK) Limited | Oral composition comprising a cooling agent |
GB2453770A (en) * | 2007-10-19 | 2009-04-22 | Reckitt Benckiser Healthcare | Oral composition comprising a cooling agent |
DE102007052070A1 (de) | 2007-10-30 | 2009-05-07 | Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg | Candesartancilexetil |
PL3354276T3 (pl) | 2007-11-13 | 2020-09-21 | Meritage Pharma, Inc. | Kompozycje do leczenia zapalenia przewodu pokarmowego |
TR201808694T4 (tr) * | 2008-06-20 | 2018-07-23 | Merck Patent Gmbh | Doğrudan sıkıştırılabilen ve hızlı parçalanan tablet matrisi. |
WO2010133638A1 (de) | 2009-05-20 | 2010-11-25 | Boehringer Ingelheim Vetmedica Gmbh | Pharmazeutische telmisartan-trinklösung |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
WO2011019043A1 (ja) | 2009-08-11 | 2011-02-17 | 大日本住友製薬株式会社 | 2種以上の粒子を含有する口腔内速崩壊錠 |
KR101636958B1 (ko) * | 2009-09-11 | 2016-07-06 | 주식회사 대웅제약 | 우루소데옥시콜린산-합성하이드로탈사이트-유드라짓 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법 |
PL2493457T3 (pl) | 2009-10-30 | 2018-01-31 | Ix Biopharma Ltd | Szybko rozpuszczalna stała postać dawkowana |
US20130052266A1 (en) * | 2010-05-11 | 2013-02-28 | Mitsubishi Tanabe Pharma Corporation | TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND |
US8877221B2 (en) | 2010-10-27 | 2014-11-04 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same |
US9107983B2 (en) | 2010-10-27 | 2015-08-18 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising statins |
WO2012170417A2 (en) | 2011-06-06 | 2012-12-13 | Warsaw Orthopedic, Inc. | Methods and compositions to enhance bone growth comprising a statin |
IN2014DN07797A (ja) * | 2012-03-29 | 2015-05-15 | Daicel Corp | |
JP6230539B2 (ja) * | 2012-09-20 | 2017-11-15 | 株式会社ダイセル | 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤 |
CN105517576A (zh) * | 2013-07-06 | 2016-04-20 | 株式会社大赛璐 | 超速崩解片剂及其制备方法 |
JP6469234B2 (ja) * | 2015-09-04 | 2019-02-13 | 株式会社ダイセル | 超速崩壊錠剤及びその製造方法 |
US11278506B2 (en) | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
US20200268650A1 (en) * | 2016-01-18 | 2020-08-27 | Daicel Corporation | Intraoral retentive disintegrating solid preparation, method for producing same and powder composition used in said production method |
WO2019008485A1 (en) | 2017-07-06 | 2019-01-10 | Mankind Pharma Ltd | FIXED DOSE PHARMACEUTICAL COMPOSITION BASED ON VALSARTAN AND SACUBITRIL |
WO2024023786A1 (en) | 2022-07-29 | 2024-02-01 | Berlia Sushma Paul | Orally disintegrating palatable formulations of drotaverine and method of preparation thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0839526A2 (en) * | 1996-10-31 | 1998-05-06 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
JPH1135486A (ja) * | 1997-07-23 | 1999-02-09 | Lion Corp | 薬用固形製剤 |
EP0922464A1 (en) * | 1996-07-12 | 1999-06-16 | Daiichi Pharmaceutical Co., Ltd. | Quickly disintegrable compression-molded materials and process for producing the same |
JP2000273039A (ja) * | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | 口腔内崩壊性組成物 |
JP2001058944A (ja) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8730011D0 (en) | 1987-12-23 | 1988-02-03 | Smithkline Dauelsberg | Pharmaceutical compositions |
EP0481294B2 (de) * | 1990-10-19 | 2001-04-11 | Spirig Ag Pharmazeutische Präparate | Feste, schnell-lösliche Arzneimittelzubereitung enthaltend N-Acetylcystein |
JP3454517B2 (ja) | 1991-04-25 | 2003-10-06 | 京都薬品工業株式会社 | 矯味経口剤 |
JP3265680B2 (ja) | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
US5785984A (en) * | 1993-02-05 | 1998-07-28 | Kao Corporation | Taste-modifying method and bitterness-decreasing method |
JPH07285868A (ja) | 1994-04-13 | 1995-10-31 | Kissei Pharmaceut Co Ltd | ピロリジン誘導体を含有する医薬品製剤 |
FR2722408B1 (fr) | 1994-07-15 | 1996-10-04 | Vacher Dominique | Nouveau procede de realisation de formes pharmaceutiques seches a delitement quasiment instantane etles formes pharmaceutiques ainsi realisees |
JPH10114655A (ja) | 1996-10-09 | 1998-05-06 | Kyowa Hakko Kogyo Co Ltd | 固形製剤 |
JPH10236947A (ja) | 1997-02-21 | 1998-09-08 | Dai Ichi Seiyaku Co Ltd | マスキング剤 |
JP3770518B2 (ja) | 1997-03-28 | 2006-04-26 | エーザイ株式会社 | 苦味等を隠蔽した経口薬剤 |
JP3783993B2 (ja) | 1997-07-24 | 2006-06-07 | エーザイ株式会社 | 製剤組成物及びその製造方法 |
US6589554B1 (en) * | 1998-03-16 | 2003-07-08 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets quickly disintegrating in the oral cavity and process for producing the same |
JP3310233B2 (ja) | 1999-02-17 | 2002-08-05 | 第一工業製薬株式会社 | 錠剤用崩壊剤 |
US6559188B1 (en) * | 1999-09-17 | 2003-05-06 | Novartis Ag | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
-
2001
- 2001-10-05 AU AU2001294192A patent/AU2001294192A1/en not_active Abandoned
- 2001-10-05 EP EP01974700A patent/EP1329217A4/en not_active Withdrawn
- 2001-10-05 CA CA002424770A patent/CA2424770A1/en not_active Abandoned
- 2001-10-05 WO PCT/JP2001/008785 patent/WO2002030400A1/ja active Application Filing
- 2001-10-05 US US10/398,434 patent/US7510728B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0922464A1 (en) * | 1996-07-12 | 1999-06-16 | Daiichi Pharmaceutical Co., Ltd. | Quickly disintegrable compression-molded materials and process for producing the same |
EP0839526A2 (en) * | 1996-10-31 | 1998-05-06 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
JPH1135486A (ja) * | 1997-07-23 | 1999-02-09 | Lion Corp | 薬用固形製剤 |
JP2000273039A (ja) * | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | 口腔内崩壊性組成物 |
JP2001058944A (ja) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004030700A1 (ja) * | 2002-10-07 | 2004-04-15 | Takeda Pharmaceutical Company Limited | 固形製剤 |
EP1561472A4 (en) * | 2002-10-07 | 2009-07-08 | Takeda Pharmaceutical | SOLID PREPARATION |
US9101660B2 (en) | 2002-10-07 | 2015-08-11 | Takeda Pharmaceutical Company | Solid preparation |
EP1561472B2 (en) † | 2002-10-07 | 2021-01-20 | Takeda Pharmaceutical Company Limited | Solid preparation |
WO2005037254A1 (ja) * | 2003-10-15 | 2005-04-28 | Fuji Chemical Industry Co., Ltd. | 口腔内速崩壊性錠剤 |
US8647668B2 (en) | 2003-10-15 | 2014-02-11 | Fuji Chemical Industry Co., Ltd. | Tablet quickly disintegrating in oral cavity |
US8632808B2 (en) | 2006-04-27 | 2014-01-21 | Takeda Pharmaceutical Company Limited | Taste-masking solid preparation of pioglitazone |
WO2007136129A1 (en) * | 2006-05-23 | 2007-11-29 | Takeda Pharmaceutical Company Limited | Oral preparation comprising pioglitazone |
JP2009538268A (ja) * | 2006-05-23 | 2009-11-05 | 武田薬品工業株式会社 | ピオグリタゾンを含有する経口剤 |
US8865217B2 (en) | 2006-05-23 | 2014-10-21 | Takeda Pharmaceutical Company Limited | Oral preparation comprising pioglitazone |
WO2013129436A1 (ja) * | 2012-02-29 | 2013-09-06 | 武田薬品工業株式会社 | 経口剤 |
Also Published As
Publication number | Publication date |
---|---|
US7510728B2 (en) | 2009-03-31 |
EP1329217A1 (en) | 2003-07-23 |
CA2424770A1 (en) | 2003-04-03 |
EP1329217A4 (en) | 2007-04-04 |
US20040033258A1 (en) | 2004-02-19 |
AU2001294192A1 (en) | 2002-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002030400A1 (fr) | Preparations solides | |
JP4284017B2 (ja) | 固形製剤 | |
TWI572371B (zh) | 口腔內崩壞錠及其製造方法 | |
KR101465803B1 (ko) | 구강내 붕괴 정제 | |
JP5674667B2 (ja) | 崩壊性粒子組成物及び口腔内速崩壊錠 | |
WO2007074856A1 (ja) | 口腔内崩壊性固形製剤の製造法 | |
JP2001058944A (ja) | 速崩壊性固形製剤 | |
JP6919119B2 (ja) | 3位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 | |
CN109996542A (zh) | 包含二胺衍生物的口腔崩解片 | |
WO2007119792A1 (ja) | 乾式直打速崩壊性錠剤 | |
JP2017141299A (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
JP2003034655A (ja) | 速崩壊性固形製剤 | |
US20160136097A1 (en) | Ultrafast-disintegrating tablet and method for manufacturing same | |
US10864165B2 (en) | Super-rapid disintegrating tablet, and method for producing same | |
TWI731846B (zh) | 超高速崩解錠劑及其製造方法 | |
Joseph et al. | A review on current applications of bilayer tablets | |
JP5978335B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
JPH11116465A (ja) | 迅速溶解性製剤およびその製造法 | |
JP6151413B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
CN104434860A (zh) | 包合工艺制备的盐酸氨溴索渗透泵型药物组合物 | |
JP5714652B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
JP2008280316A (ja) | 経口投与用錠剤 | |
JP2021113237A (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
WO2002092058A1 (fr) | Preparation solide se desintegrant rapidement | |
CN107296798A (zh) | 抗发红组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10398434 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2424770 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001974700 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001974700 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |